Submission date
30/09/2005
Registration date
30/09/2005
Last edited
14/04/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Retrospectively registered
? Protocol not yet added
? SAP not yet added
Results added
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr A Ng

ORCID ID

Contact details

University Hospitals of Leicester
University Hospitals of Leicester
c/o Research and Development Office
Leicester General Hospital NHS Trust
Leicester
LE1 4PW
United Kingdom

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

N0123138268

Study information

Scientific title

Acronym

Study hypothesis

To investigate the analgesic effects and benefits of parecoxib.

Ethics approval(s)

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Not specified

Study type

Not Specified

Patient information sheet

Condition

Post-operative pain

Intervention

All patients were given intraoperative:
1. Propofol 2 - 4 mg kg intravenously (i.v.)
2. Morphine 10 mg i.v.
3. Prochlorperazine 12.5 mg intramuscularly (i.m.)

Patients' lungs were ventilated with nitrous oxide and isoflurane 1 - 1.5% in oxygen, and morphine was self-administered for postoperative analgesia via a patient controlled analgesia (PCA) device.

Patients were allocated randomly to receive either parecoxib 40 mg i.v. or normal saline on induction of anaesthesia.

Intervention type

Other

Primary outcome measure

1. Morphine consumption
2. Pain
3. Sedation
4. Nausea

Secondary outcome measures

Not provided at time of registration

Overall study start date

15/05/2002

Overall study end date

01/04/2003

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

1. Patients having total abdominal hysterectomy
2. American Society of Anesthesiologists (ASA) 1-11
3. Aged 20 - 65, female

Participant type(s)

Patient

Age group

Adult

Sex

Female

Target number of participants

21 controls/21 patients

Participant exclusion criteria

1. Patients having hysterectomy/morphine consumption
2. Pain
3. Sedation
4. Nausea

Recruitment start date

15/05/2002

Recruitment end date

01/04/2003

Locations

Countries of recruitment

England, United Kingdom

Study participating centre

University Hospitals of Leicester
Leicester
LE1 4PW
United Kingdom

Sponsor information

Organisation

Department of Health

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Funder name

University Hospitals of Leicester NHS Trust (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

Departmental funding

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/06/2003 Yes No

Additional files

Editorial Notes